John Whitesides
UCB Pharma (United States)(US)
Publications by Year
Research Areas
Epilepsy research and treatment, Pharmacological Effects and Toxicity Studies, Neuroscience and Neuropharmacology Research, Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments
Most-Cited Works
- → Rotigotine effects on early morning motor function and sleep in Parkinson's disease: A double‐blind, randomized, placebo‐controlled study (RECOVER)(2010)439 cited
- → A randomized, double‐blind, placebo‐controlled, multicenter, parallel‐group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial‐onset seizures(2015)229 cited
- → Efficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studies(2016)110 cited
- → Intravenous lacosamide as replacement for oral lacosamide in patients with partial‐onset seizures(2007)110 cited
- → A review of the pharmacology and clinical efficacy of brivaracetam(2018)98 cited
- → Intravenous lacosamide as short‐term replacement for oral lacosamide in partial‐onset seizures(2009)74 cited
- → Safety, tolerability, and seizure control during long‐term treatment with adjunctive brivaracetam for partial‐onset seizures(2016)71 cited
- → Safety and tolerability of adjunctive brivaracetam in epilepsy: In-depth pooled analysis(2020)49 cited
- → A Randomized Study of Rotigotine Dose Response on ‘Off’ Time in Advanced Parkinson's Disease(2014)45 cited
- → Rotigotine's effect on PLM-associated blood pressure elevations in restless legs syndrome(2016)43 cited